The tainted blood tragedy is incontestably the worst public health disaster that Canada has ever faced.
Today, October 27, anniversary of the creation of the Krever Commission, we pause to remember those who have passed away and to honour those who are living with the consequences of HIV and hepatitis C infection as a result of the tainted blood tragedy.
Today, we salute our heroes.
Click on the following link for all the details of the job offer:
NATIONAL COMMUNITY PROGRAMS MANAGER
DEADLINE TO APPLY: November 18, 2022
The CHS is announcing its Call for Applications for its research programs for the 2023-2024 grant period.
The deadline to submit applications for all the programs is December 16, 2022.
CLICK HERE for all the details and links to apply.
“The CHS strongly supports Canadian Blood Services’ plans to work with a leading company in the plasma industry to collect more domestic plasma and have it fractionated in Canada for Canadian patients,” said Wendy Quinn, CHS President, after today’s announcement by CBS to create a partnership with Grifols Canada.
CLICK HERE TO ACCESS THE FULL STATEMENT
Following reactions to the recent Canadian Blood Services’ statement regarding its ongoing discussions with governments and the commercial plasma industry to increase domestic plasma collection so that at least 50% of immunoglobulins are made from plasma collected in Canada, the Network of Rare Blood Disorder Organizations, of which the CHS is a member, sent a letter to the federal, provincial and territorial health ministers to confirm its support for CBS’ latest analysis.
CLICK HERE to read the letter.
The CHS educational catalogue has been updated to include its newly revised FactorFirst card.
The CHS and its chapters are pleased to extend their support to the best of their capacity to Ukrainian refugees with bleeding disorders that have landed in Canada.
CLICK HERE for information about the range of support chapters can offer.
